Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joan C. Y. Ng"'
Autor:
Brooke Gessner, PharmD, ACPR, Michelle Carter, RN, MSN, Kiana Rahnama, BSc, PharmD, ACPR, Alberto Almeida, MPH, PMP, Colleen Borralho, MHS, BSPN, BA, RPN, Tamara Mihic, BSc, ACPR, PharmD, Joan C. Y. Ng, BSc, ACPR, PharmD, Joseph H. Puyat, MA, MSc, PhD, Angela Russolillo, PhD, MSc, RPN, Katelyn C. Halpape, BSP, ACPR, PharmD, BCPP
Publikováno v:
Mental Health Clinician, Vol 14, Iss 2, Pp 85-91 (2024)
Introduction Clozapine is the most effective antipsychotic in the management of treatment-resistant schizophrenia; however, its use is challenging due to the risk of severe adverse effects. Despite the risks associated with clozapine, there is no man
Externí odkaz:
https://doaj.org/article/7056c5b645944b208393840e0dd9a970
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5:132-140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09ae360f61313c7832f85f06107e64ca
https://doi.org/10.1002/jac5.1555
https://doi.org/10.1002/jac5.1555
Publikováno v:
Journal of the American Psychiatric Nurses Association. 29:103-111
BACKGROUND: Pro re nata (PRN) antipsychotics and benzodiazepines are routinely used for the rapid stabilization of acutely agitated patients. Despite the popular use of PRN medications in mental health units, primary literature supporting efficacy an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5171747f1f7f519cdb7a09cce7b3c26
https://doi.org/10.1177/1078390321994668
https://doi.org/10.1177/1078390321994668
Publikováno v:
Clinical pharmacokinetics. 56(9)
Leflunomide is an immunosuppressive drug with in vitro and initial observational evidence of antiviral activity against BK virus (BKV), a pathogen that causes opportunistic infection upon reactivation in renal transplant recipients. Leflunomide is co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43816f35d693c1a8234118f6a8c8e371
https://pubmed.ncbi.nlm.nih.gov/28247238
https://pubmed.ncbi.nlm.nih.gov/28247238
Autor:
Casol M; Marina Casol, BSc (Pharm), ACPR, Surrey Memorial Hospital, Surrey, British Columbia, Canada., Tong A; Angela Tong, BSc (Pharm), ACPR, Surrey Memorial Hospital, Surrey, British Columbia, Canada; University of British Columbia, Vancouver, British Columbia, Canada., Ng JCY; Joan C. Y. Ng, BSc (Pharm), ACPR, PharmD, University of British Columbia, Vancouver, British Columbia, Canada; St. Paul's Hospital, Vancouver, British Columbia, Canada., McGloin R; Rumi McGloin, BSc (Pharm), ACPR, PharmD, Surrey Memorial Hospital, Surrey, British Columbia, Canada; University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
Journal of the American Psychiatric Nurses Association [J Am Psychiatr Nurses Assoc] 2023 Mar-Apr; Vol. 29 (2), pp. 103-111. Date of Electronic Publication: 2021 Jun 10.